Wyeth, Schwartz Ask 10th Circ. To Nix Suit Over Generic Reglan

Law360, New York (August 30, 2012, 9:32 PM EDT) -- Wyeth Inc. and Schwarz Pharma Inc. on Wednesday asked the Tenth Circuit to toss for lack of jurisdiction an appeal by an Oklahoma couple who claim the pharmaceutical companies failed to warn the public about serious side effects from generic versions of their brand-name anti-heartburn drug Reglan.

In their brief before the Tenth Circuit, the companies said Susan and Steve Schrock’s appeal of an Oklahoma federal court’s 2009 decision to grant Wyeth and Schwarz summary judgment is untimely since it comes three years afterward. As such,...
To view the full article, register now.




Case Information

Case Title

Schrock et al v. Wyeth Inc et al

Case Number



Oklahoma Western

Nature of Suit

Personal Inj. Prod. Liability


Vicki Miles-LaGrange

Date Filed

April 30, 2008

Law Firms


UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.